Picture of Aurinia Pharmaceuticals logo

AUPH — Aurinia Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Brief: MKT Capital Urges Aurinia Pharma To Commit To Strategic Review Process

May 17 (Reuters) - MKT Capital Ltd:
    * MKT CAPITAL:GEORGE MILNE, JOSEPH HAGAN GOT LESS THAN
MAJORITY
SUPPORT FROM SHAREHOLDERS, RESULTED IN  RESIGNATIONS FROM
AURINIA PHARMACEUTICALS BOARD
    * MKT CAPITAL LTD:  EXECUTIVE COMPENSATION PROPOSAL DID NOT
RECEIVE MAJORITY SUPPORT AT  AURINIA PHARMACEUTICALS' 2023
ANNUAL GENERAL MEETING
    * MKT CAPITAL LTD- URGES AURINIA PHARMACEUTICALS BOARD TO
PUBLICLY
COMMIT TO A STRATEGIC REVIEW PROCESS

Source text for Eikon:  ID:nBw4NxVBva 
Further company coverage:  AUPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aurinia Pharmaceuticals

See all news